- Filed
- Mar 11, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · Mar 4, 2026 | 51.89M sh |
| Shares Diluted | Q3 2026 · Jan 31, 2026 | 52.42M sh |
| Shares Diluted | Q3 2026 · Jan 31, 2026 | 52.61M sh |
| Shares Diluted | Q3 2026 · Jan 31, 2025 | 52.36M sh |
| Shares Diluted | Q3 2026 · Jan 31, 2025 | 52.79M sh |
| Stock Repurchased | Q3 2026 · Jan 31, 2026 | $37.63M |
| Stock Repurchased | Q3 2026 · Jan 31, 2025 | $73.92M |
| Dividends Paid | Q3 2026 · Jan 31, 2026 | $76.37M |
| Dividends Paid | Q3 2026 · Jan 31, 2025 | $58.58M |
| Capex | Q3 2026 · Jan 31, 2026 | $65.08M |
| Capex | Q3 2026 · Jan 31, 2025 | $42.19M |
| Operating Cash Flow | Q3 2026 · Jan 31, 2026 | $117.51M |
| Operating Cash Flow | Q3 2026 · Jan 31, 2025 | $108.55M |
| Long Term Debt | Q3 2026 · Jan 31, 2026 | $398.35M |
| Long Term Debt | Q3 2026 · Apr 30, 2025 | $397.74M |
| Cash And Equivalents | Q3 2026 · Jan 31, 2026 | $938.37M |
| Cash And Equivalents | Q3 2026 · Apr 30, 2025 | $1.01B |
| Stockholders Equity | Q3 2026 · Jan 31, 2026 | $2B |
| Stockholders Equity | Q3 2026 · Apr 30, 2025 | $1.87B |
| Current Liabilities | Q3 2026 · Jan 31, 2026 | $889.56M |
| Current Liabilities | Q3 2026 · Apr 30, 2025 | $955.6M |
| Total Liabilities | Q3 2026 · Jan 31, 2026 | $1.94B |
| Total Liabilities | Q3 2026 · Apr 30, 2025 | $1.99B |
| Current Assets | Q3 2026 · Jan 31, 2026 | $1.79B |
| Current Assets | Q3 2026 · Apr 30, 2025 | $1.75B |
| Total Assets | Q3 2026 · Jan 31, 2026 | $3.95B |
| Total Assets | Q3 2026 · Apr 30, 2025 | $3.86B |
| Eps Diluted | Q3 2026 · Jan 31, 2026 | $1.23 |
| Eps Diluted | Q3 2026 · Jan 31, 2026 | $3.84 |
| Eps Diluted | Q3 2026 · Jan 31, 2025 | $1.10 |
| Eps Diluted | Q3 2026 · Jan 31, 2025 | $3.40 |
| Eps Basic | Q3 2026 · Jan 31, 2026 | $1.25 |
| Eps Basic | Q3 2026 · Jan 31, 2026 | $3.91 |
| Eps Basic | Q3 2026 · Jan 31, 2025 | $1.12 |
| Eps Basic | Q3 2026 · Jan 31, 2025 | $3.46 |
| Sga Expense | Q3 2026 · Jan 31, 2026 | $65.94M |
| Sga Expense | Q3 2026 · Jan 31, 2026 | $180.07M |
| Sga Expense | Q3 2026 · Jan 31, 2025 | $65.33M |
| Sga Expense | Q3 2026 · Jan 31, 2025 | $189.87M |
| Net Income | Q3 2026 · Jan 31, 2026 | $65.27M |
| Net Income | Q3 2026 · Jan 31, 2026 | $204.3M |
| Net Income | Q3 2026 · Jan 31, 2025 | $58.41M |
| Net Income | Q3 2026 · Jan 31, 2025 | $181.82M |
| Operating Income | Q3 2026 · Jan 31, 2026 | $91.02M |
| Operating Income | Q3 2026 · Jan 31, 2026 | $273.22M |
| Operating Income | Q3 2026 · Jan 31, 2025 | $78.23M |
| Operating Income | Q3 2026 · Jan 31, 2025 | $241.76M |
| Revenue | Q3 2026 · Jan 31, 2026 | $725.04M |
| Revenue | Q3 2026 · Jan 31, 2026 | $2.17B |
| Revenue | Q3 2026 · Jan 31, 2025 | $676.54M |
| Revenue | Q3 2026 · Jan 31, 2025 | $2.04B |